Natural Health New s – A new economic analysis that exposure to endocrine disruptor chemicals the likely costs the EU € 157 billion ($ 137,209 / £ million) per year in real expenditures for health care and the potential loss of revenue.
Global experts in this field, the announcement of the results, concluded that infertility and male reproductive disorders, birth defects, obesity, diabetes, cardiovascular disease and neurobehavioral and learning disorders they are among the conditions that can be attributed in part to exposure to endocrine -disrupting chemicals (EDC).
The € 157 billion estimate is conservative, and represents 1.23% of European gross domestic product (GDP). These costs may actually be as high as € 270 billion ($ 359/236 £ trillion), or 2% of GDP.
A staggering cost
“Analysis shows how to stagger the cost of extended chemical exposure endocrine disorders is to society,” said Leonardo Trasande, MD, MPP, Professor associate Professor of Pediatrics, Environmental Medicine and Population Health of the NYU Langone Medical Center, who led a team of researchers through eighteen eight countries of this historical research. “This research crystallizes more than three decades of laboratory and population-based studies of endocrine disruptors in the EU.”
EDC mimic, block or interfere with the body’s hormones. EDC include bisphenol A (BPA) found in water bottles and can coatings, certain phthalates are in plastic products and cosmetics, flame retardants, and pesticides such as chlorpyrifos.
Almost 100% of people have detectable amounts of EDC in their bodies, according to the Introductory Guide to the EDC published by the Society of Endocrinology and IPEN .
Based on the body of established literature, a panel of world experts EDC assesses the likelihood that EDC contributed to various medical conditions and dysfunctions, but limits the analysis to disorders with the strongest scientific evidence .
The analysis included the direct costs of hospitalization, medical services, nursing care and other medical expenses. The researchers also calculated estimates of indirect costs such as lost productivity, premature death and disability.
“Although this analysis was limited to the European Union, is likely to be in the same order of magnitude in the United States and elsewhere, the disease burden and cost of the exhibition” Trasande said.
The loss of our mind, weight gain
In the EU, the researchers found that the driver biggest cost was the loss of IQ and disability intellectual caused by prenatal exposure to organophosphate pesticides containing. The study estimated the damage caused to unborn children costs society between € 46.8 billion ($ 51 / £ 33 billion) and 195 million ($ 140 million 214 / £) € per year. Around 13 million points of CI lost and 59,300 new cases of intellectual disabilities per year can be attributed to exposure to these products.
adult obesity linked to phthalate exposure generated the second-highest total, with estimated costs of € 15.6 billion a year.
“Our results show that limiting exposure to the most common and dangerous endocrine-disrupting chemicals is likely to produce significant economic benefits,” said one of the study authors, Philippe Grandjean, MD, PhD, professor of Environmental Medicine at the University of Southern Denmark and adjunct professor at the University of Harvard TH Chan School of Public Health.
“This approach has the potential to inform decision-making in the field of environmental health. We are hoping to bring the latest endocrine science to the attention of politicians, as they weigh how to regulate these products toxic chemicals “.
The results are published in a series of studies published in Journal of Clinical Endocrinology Society of Endocrinology and Metabolism .
- The study Cost estimation of the burden of disease and exposure to chemicals that cause endocrine disruption in the European Union can be found here
- the study costs obesity, diabetes, and associated services of exposure to chemicals that cause endocrine disruption in the European Union can be found here
- study the neurobehavioral deficits, diseases and costs associated with exposure to endocrine disruptors in the European Union can be found here
- the study disorders male reproductive diseases and costs of exposure to chemicals endocrine-disrupting in the European Union can be found here